Amsterdam Investigator–initiateD Absorb strategy all-comers trial (AIDA trial): A clinical evaluation comparing the efficacy and performance of ABSORB everolimus-eluting bioresorbable vascular scaffold strategy vs the XIENCE family (XIENCE PRIME or XIENCE Xpedition) everolimus-eluting coronary stent strategy in the treatment of coronary lesions in consecutive all-comers: Rationale and study design
Title:
Amsterdam Investigator–initiateD Absorb strategy all-comers trial (AIDA trial): A clinical evaluation comparing the efficacy and performance of ABSORB everolimus-eluting bioresorbable vascular scaffold strategy vs the XIENCE family (XIENCE PRIME or XIENCE Xpedition) everolimus-eluting coronary stent strategy in the treatment of coronary lesions in consecutive all-comers: Rationale and study design
Author:
Woudstra, Pier Grundeken, Maik J. Kraak, Robin P. Hassell, Mariëlla E.C.J. Arkenbout, E. Karin Baan Jr, Jan Vis, Marije M. Koch, Karel T. Tijssen, Jan G.P. Piek, Jan J. de Winter, Robbert J. Henriques, José P.S. Wykrzykowska, Joanna J.